Hospitalized patients who smoke may be more likely to quit smoking through the use of hypnotherapy than patients using other smoking cessation methods according to a new study presented at CHEST 2007,the annual meeting of the American College of Chest Physicians (ACCP).

Smoking patients who participated in one hypnotherapy session were more likely to be nonsmokers at 6 months compared with patients using nicotine replacement therapy (NRT) alone or patients who quit “cold turkey”. The study also shows that patients admitted to the hospital with a cardiac diagnosis are three times more likely to quit smoking at 6 months than patients admitted with a pulmonary diagnosis.

Without sleep, the emotional centers of the brain dramatically overreact to negative experiences, reveals a new brain imaging study in Current Biology.   The reason for that hyperactive emotional response in sleep-deprived people stems from a shutdown of the prefrontal lobe—a region that normally keeps emotions under control.

The new study from Harvard Medical School and the University of California, Berkeley is the first to explain, at the neural level, what seems to be a universal phenomenon: that sleep loss leads to emotionally irrational behavior, according to the researchers. The findings might also offer some insight into the clinical connection between sleep disruptions and psychiatric disorders.

Height may point to a biological basis for pedophilia, according to new research released by the Centre for Addiction and Mental Health (CAMH). The study found that pedophilic males were shorter on average than males without a sexual attraction to children.

The study, published in Sexual Abuse: A Journal of Research and Treatment, suggests that pedophiles may have been exposed to pre-birth conditions that affected their physical development. The researchers observed this height difference by analyzing the files of over 1,000 men who were assessed for pedophilia or other sexual disorders between 1995 and 2006 at the Kurt Freund Laboratory in Toronto, Canada.

A difference in average height is a trait found in other illnesses with biological links.

Philosophers and scientists have long been interested in how the mind processes the inevitability of death, both cognitively and emotionally. One would expect, for example, that reminders of our mortality - like the sudden death of a loved one - would throw us into a state of disabling fear of the unknown. But that doesn't happen. If the prospect of death is so incomprehensible, why are we not trembling in a constant state of terror over this fact?

Psychologists have some ideas about how we cope with existential dread. One emerging idea--"terror management theory" --holds that the brain is hard-wired to keep us from being paralyzed by fear.

Researchers have found that vaccination against influenza strains seems to be more effective in a semi-urban population than in a rural population of schoolchildren in Gabon, Africa, according to an article in the Dec. 1 issue of The Journal of Infectious Diseases. The study suggests that infection with parasites and/or poor nutrition may have an impact on the effectiveness of influenza vaccine.

Lead author E. van Riet (Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands) and a team of researchers analyzed antibody and cellular responses to influenza A and B strains in 33 children from a semi-urban school in Lambaréné in Gabon, Africa, and 22 children from a rural area nearby.

Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans. David Thorley-Lawson, PhD, professor of pathology at Tufts University School of Medicine, is combining PathSim, laboratory methods, and clinical studies to provide a new and powerful approach to understanding EBV and ultimately designing anti-viral therapies.

“PathSim is an agent-based computer program. The agents are the virus itself, and the T and B cells of the patient’s immune system,” explains Thorley-Lawson. Using PathSim, Thorley-Lawson can manipulate these agents to simulate EBV infection and persistence in humans.